| [1] |
WU Duo-Jiao, HONG Hua-Shan.
Progress of medication in myocardial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(12): 1327-1332.
|
| [2] |
CHEN Shao-Liang, DUAN Bao-Xiang, YE Fei, FANG Wu-Wang, HU Zuo-Ying, HUANG Jing, DAI Zhen-Ling, ZHOU Lin, LUO Jun, LIN Song, ZHA Ming-Fan, GEN Qi-Ji.
Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2001, 6(4): 301-306.
|
| [3] |
ZHANG Chun-Fen, WANG Qing, ZHANG Jin-Ping, DONG Hai-Xin, LI Jian-Mei, XING Qin, LUN Xue-Qing, YANG Lei, LIU Shan-Tin.
TAA-1 in treatment of experimental rabbit endocardit is induced by α-hemolytic streptococcus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(3): 191-194.
|
| [4] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1999, 4(1): 66-67.
|
| [5] |
SUN Qi, FENG Hui, WU Jun-Fang, NIU Feng-Zhen.
Inhibitory effects of Losartan on c-fos expression and intracellular free calcium elevation induced by Angiotensio Ⅱ in cardiomyocytes of neonatal rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1998, 3(4): 261-267.
|
| [6] |
WANG Chun-Xi, JIA Run-Ying, ZHAO Weng-Guang, ZANG Guang-Sheng, YAO Di.
Observation of antagonism of aescuven forte tofree oxygen radical injuries in superf icial venons vericosis of legs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1998, 3(2): 120-121.
|
